We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Wirecutter Staff You spent a pretty penny on a beautiful cashmere sweater, ...

Visualizing and quantifying DNA replication dynamics in living human cells remains challenging. Here, a new super-resolution microscopy method, 3D-SPARK, maps changes in replication nanostructures in ...

Novo Nordisk's Rybelsus has become the first oral GLP-1 agonist to pick up a regulatory approval for cardiovascular risk reduction, after getting a green light from the EMA's human medicine committee.